Browsing tag
One-third of clinical trial participants who received no vaccine reported systemic adverse advents like headache and fatigue. The placebo effect is the well-known phenomenon of…
Strong antibody response to mRNA vaccines declined over an eight-month follow-up period; lower initial response to single-shot Ad26 vaccine remained stable over time, research shows….
Massachusetts statewide study showed no significant differences in COVID-19 case rates between K-12 districts that implemented 3-feet versus 6-feet of physical distancing. As COVID-19 infection…
Study conducted at BIDMC is among the first to compare the impact of COVID-19 on patients and hospital resources versus the impact of influenza. In…
The increase in deaths occurred in states that were hit earliest by the pandemic — with the exception of Massachusetts. As the number of COVID-19…
New metrics and forecasting models are key to understanding and anticipating the challenges of the COVID-19 pandemic. The COVID-19 pandemic has fundamentally disrupted U.S. healthcare…
Findings lay groundwork for clinical development program. The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A…
Companion study suggests COVID-19 infection protects against re-exposure. With nearly 5 million confirmed cases globally and more than 300,000 deaths from COVID-19, much remains unknown…
HMS researchers at Beth Israel Deaconess Medical Center examined the current literature on the safety and efficacy of selective serotonin reuptake inhibitor (SSRI) use in…
New research from scientists at Beth Israel Deaconess Medical Center provides key insights into the basic biology of tumor formation and offers a potential new…